nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiaprofenic acid—Acute interstitial nephritis—Sorafenib—liver cancer	0.0841	0.138	CcSEcCtD
Tiaprofenic acid—Onycholysis—Epirubicin—liver cancer	0.0311	0.0509	CcSEcCtD
Tiaprofenic acid—Onycholysis—Doxorubicin—liver cancer	0.0288	0.0471	CcSEcCtD
Tiaprofenic acid—L-Phenylalanine—TAT—liver cancer	0.018	0.663	CrCbGaD
Tiaprofenic acid—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.0149	0.0243	CcSEcCtD
Tiaprofenic acid—Bullous eruption—Epirubicin—liver cancer	0.0106	0.0174	CcSEcCtD
Tiaprofenic acid—Bullous eruption—Doxorubicin—liver cancer	0.00985	0.0161	CcSEcCtD
Tiaprofenic acid—Dry skin—Sorafenib—liver cancer	0.00757	0.0124	CcSEcCtD
Tiaprofenic acid—Abdominal pain upper—Sorafenib—liver cancer	0.00755	0.0124	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00744	0.0122	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—EPT1—liver cancer	0.00661	0.0182	CbGpPWpGaD
Tiaprofenic acid—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00631	0.0103	CcSEcCtD
Tiaprofenic acid—Stomatitis—Sorafenib—liver cancer	0.00621	0.0102	CcSEcCtD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—HMOX1—liver cancer	0.0062	0.0171	CbGpPWpGaD
Tiaprofenic acid—Epistaxis—Sorafenib—liver cancer	0.00601	0.00983	CcSEcCtD
Tiaprofenic acid—PTGS1—Eicosanoid Synthesis—GGT1—liver cancer	0.00581	0.016	CbGpPWpGaD
Tiaprofenic acid—Haemoglobin—Sorafenib—liver cancer	0.00574	0.00941	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Sorafenib—liver cancer	0.00572	0.00936	CcSEcCtD
Tiaprofenic acid—Vaginal haemorrhage—Epirubicin—liver cancer	0.00568	0.0093	CcSEcCtD
Tiaprofenic acid—Erythema multiforme—Sorafenib—liver cancer	0.0054	0.00885	CcSEcCtD
Tiaprofenic acid—Tinnitus—Sorafenib—liver cancer	0.00533	0.00873	CcSEcCtD
Tiaprofenic acid—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00526	0.00861	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—EPT1—liver cancer	0.00525	0.0145	CbGpPWpGaD
Tiaprofenic acid—Erythema—Sorafenib—liver cancer	0.00498	0.00815	CcSEcCtD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—HMOX1—liver cancer	0.00492	0.0136	CbGpPWpGaD
Tiaprofenic acid—Muscle spasms—Sorafenib—liver cancer	0.00478	0.00783	CcSEcCtD
Tiaprofenic acid—Mebendazole—CYP1A1—liver cancer	0.00476	0.176	CrCbGaD
Tiaprofenic acid—PTGS2—Eicosanoid Synthesis—GGT1—liver cancer	0.00461	0.0127	CbGpPWpGaD
Tiaprofenic acid—Anaemia—Sorafenib—liver cancer	0.0046	0.00753	CcSEcCtD
Tiaprofenic acid—Oliguria—Epirubicin—liver cancer	0.00456	0.00747	CcSEcCtD
Tiaprofenic acid—Angioedema—Sorafenib—liver cancer	0.00455	0.00744	CcSEcCtD
Tiaprofenic acid—PTGS1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00452	0.0125	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—HPGDS—liver cancer	0.00431	0.0119	CbGpPWpGaD
Tiaprofenic acid—Oliguria—Doxorubicin—liver cancer	0.00422	0.00691	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00419	0.0116	CbGpPWpGaD
Tiaprofenic acid—Dry mouth—Sorafenib—liver cancer	0.00414	0.00678	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—UGDH—liver cancer	0.00411	0.0114	CbGpPWpGaD
Tiaprofenic acid—Melaena—Epirubicin—liver cancer	0.00411	0.00673	CcSEcCtD
Tiaprofenic acid—Cystitis noninfective—Epirubicin—liver cancer	0.00411	0.00673	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00408	0.0113	CbGpPWpGaD
Tiaprofenic acid—Cystitis—Epirubicin—liver cancer	0.00406	0.00665	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Sorafenib—liver cancer	0.00406	0.00665	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Sorafenib—liver cancer	0.00398	0.00651	CcSEcCtD
Tiaprofenic acid—Anorexia—Sorafenib—liver cancer	0.00387	0.00634	CcSEcCtD
Tiaprofenic acid—Bladder pain—Epirubicin—liver cancer	0.0038	0.00623	CcSEcCtD
Tiaprofenic acid—Melaena—Doxorubicin—liver cancer	0.0038	0.00622	CcSEcCtD
Tiaprofenic acid—Cystitis noninfective—Doxorubicin—liver cancer	0.0038	0.00622	CcSEcCtD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—PIK3CD—liver cancer	0.00377	0.0104	CbGpPWpGaD
Tiaprofenic acid—Cystitis—Doxorubicin—liver cancer	0.00376	0.00615	CcSEcCtD
Tiaprofenic acid—PTGS2—S1P1 pathway—KDR—liver cancer	0.0037	0.0102	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00366	0.0101	CbGpPWpGaD
Tiaprofenic acid—Dyspnoea—Sorafenib—liver cancer	0.00362	0.00593	CcSEcCtD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—EFNB2—liver cancer	0.0036	0.00993	CbGpPWpGaD
Tiaprofenic acid—Dyspepsia—Sorafenib—liver cancer	0.00357	0.00585	CcSEcCtD
Tiaprofenic acid—Decreased appetite—Sorafenib—liver cancer	0.00353	0.00578	CcSEcCtD
Tiaprofenic acid—Bladder pain—Doxorubicin—liver cancer	0.00352	0.00576	CcSEcCtD
Tiaprofenic acid—Fatigue—Sorafenib—liver cancer	0.0035	0.00573	CcSEcCtD
Tiaprofenic acid—Photosensitivity—Epirubicin—liver cancer	0.00348	0.00569	CcSEcCtD
Tiaprofenic acid—Constipation—Sorafenib—liver cancer	0.00347	0.00569	CcSEcCtD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00342	0.00946	CbGpPWpGaD
Tiaprofenic acid—Vascular purpura—Epirubicin—liver cancer	0.00341	0.00559	CcSEcCtD
Tiaprofenic acid—Gastrointestinal pain—Sorafenib—liver cancer	0.00332	0.00544	CcSEcCtD
Tiaprofenic acid—Hot flush—Epirubicin—liver cancer	0.00326	0.00534	CcSEcCtD
Tiaprofenic acid—Menopausal symptoms—Epirubicin—liver cancer	0.00324	0.0053	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—liver cancer	0.00323	0.00893	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—GGT1—liver cancer	0.00323	0.00891	CbGpPWpGaD
Tiaprofenic acid—Urticaria—Sorafenib—liver cancer	0.00323	0.00528	CcSEcCtD
Tiaprofenic acid—Photosensitivity—Doxorubicin—liver cancer	0.00322	0.00527	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Sorafenib—liver cancer	0.00321	0.00526	CcSEcCtD
Tiaprofenic acid—Dermatitis bullous—Epirubicin—liver cancer	0.00319	0.00523	CcSEcCtD
Tiaprofenic acid—Purpura—Epirubicin—liver cancer	0.00317	0.00519	CcSEcCtD
Tiaprofenic acid—Vascular purpura—Doxorubicin—liver cancer	0.00316	0.00517	CcSEcCtD
Tiaprofenic acid—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00305	0.005	CcSEcCtD
Tiaprofenic acid—Hot flush—Doxorubicin—liver cancer	0.00302	0.00494	CcSEcCtD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—PIK3CD—liver cancer	0.00299	0.00827	CbGpPWpGaD
Tiaprofenic acid—Menopausal symptoms—Doxorubicin—liver cancer	0.00299	0.0049	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Sorafenib—liver cancer	0.00299	0.0049	CcSEcCtD
Tiaprofenic acid—Dermatitis bullous—Doxorubicin—liver cancer	0.00296	0.00484	CcSEcCtD
Tiaprofenic acid—Purpura—Doxorubicin—liver cancer	0.00293	0.0048	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—GPX3—liver cancer	0.00292	0.00806	CbGpPWpGaD
Tiaprofenic acid—Asthenia—Sorafenib—liver cancer	0.00291	0.00477	CcSEcCtD
Tiaprofenic acid—Pruritus—Sorafenib—liver cancer	0.00287	0.0047	CcSEcCtD
Tiaprofenic acid—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00283	0.00463	CcSEcCtD
Tiaprofenic acid—Dry skin—Epirubicin—liver cancer	0.0028	0.00458	CcSEcCtD
Tiaprofenic acid—Abdominal pain upper—Epirubicin—liver cancer	0.00279	0.00457	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Sorafenib—liver cancer	0.00278	0.00455	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00275	0.0045	CcSEcCtD
Tiaprofenic acid—Dizziness—Sorafenib—liver cancer	0.00269	0.0044	CcSEcCtD
Tiaprofenic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—liver cancer	0.00268	0.00739	CbGpPWpGaD
Tiaprofenic acid—Asthma—Epirubicin—liver cancer	0.00264	0.00432	CcSEcCtD
Tiaprofenic acid—Dry skin—Doxorubicin—liver cancer	0.00259	0.00424	CcSEcCtD
Tiaprofenic acid—Vomiting—Sorafenib—liver cancer	0.00258	0.00423	CcSEcCtD
Tiaprofenic acid—Abdominal pain upper—Doxorubicin—liver cancer	0.00258	0.00422	CcSEcCtD
Tiaprofenic acid—Angina pectoris—Epirubicin—liver cancer	0.00257	0.00421	CcSEcCtD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—GGT1—liver cancer	0.00256	0.00708	CbGpPWpGaD
Tiaprofenic acid—Rash—Sorafenib—liver cancer	0.00256	0.00419	CcSEcCtD
Tiaprofenic acid—Dermatitis—Sorafenib—liver cancer	0.00256	0.00419	CcSEcCtD
Tiaprofenic acid—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00254	0.00417	CcSEcCtD
Tiaprofenic acid—Headache—Sorafenib—liver cancer	0.00254	0.00416	CcSEcCtD
Tiaprofenic acid—PTGS1—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00253	0.00698	CbGpPWpGaD
Tiaprofenic acid—Dysuria—Epirubicin—liver cancer	0.00247	0.00404	CcSEcCtD
Tiaprofenic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00246	0.0068	CbGpPWpGaD
Tiaprofenic acid—Asthma—Doxorubicin—liver cancer	0.00244	0.004	CcSEcCtD
Tiaprofenic acid—Pollakiuria—Epirubicin—liver cancer	0.00244	0.00399	CcSEcCtD
Tiaprofenic acid—Nausea—Sorafenib—liver cancer	0.00241	0.00395	CcSEcCtD
Tiaprofenic acid—Photosensitivity reaction—Epirubicin—liver cancer	0.00241	0.00394	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—NR1H4—liver cancer	0.0024	0.00663	CbGpPWpGaD
Tiaprofenic acid—Weight increased—Epirubicin—liver cancer	0.0024	0.00393	CcSEcCtD
Tiaprofenic acid—Angina pectoris—Doxorubicin—liver cancer	0.00238	0.00389	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTA3—liver cancer	0.00236	0.00652	CbGpPWpGaD
Tiaprofenic acid—Drowsiness—Epirubicin—liver cancer	0.00235	0.00385	CcSEcCtD
Tiaprofenic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—liver cancer	0.00234	0.00645	CbGpPWpGaD
Tiaprofenic acid—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00233	0.00382	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—GPX3—liver cancer	0.00232	0.0064	CbGpPWpGaD
Tiaprofenic acid—Stomatitis—Epirubicin—liver cancer	0.00229	0.00376	CcSEcCtD
Tiaprofenic acid—Conjunctivitis—Epirubicin—liver cancer	0.00229	0.00374	CcSEcCtD
Tiaprofenic acid—Dysuria—Doxorubicin—liver cancer	0.00228	0.00374	CcSEcCtD
Tiaprofenic acid—Sweating—Epirubicin—liver cancer	0.00226	0.00369	CcSEcCtD
Tiaprofenic acid—Pollakiuria—Doxorubicin—liver cancer	0.00226	0.00369	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—MAPK14—liver cancer	0.00225	0.00622	CbGpPWpGaD
Tiaprofenic acid—Haematuria—Epirubicin—liver cancer	0.00224	0.00367	CcSEcCtD
Tiaprofenic acid—Photosensitivity reaction—Doxorubicin—liver cancer	0.00223	0.00365	CcSEcCtD
Tiaprofenic acid—Weight increased—Doxorubicin—liver cancer	0.00222	0.00364	CcSEcCtD
Tiaprofenic acid—Epistaxis—Epirubicin—liver cancer	0.00222	0.00363	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—liver cancer	0.00221	0.0061	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—TNF—liver cancer	0.0022	0.00607	CbGpPWpGaD
Tiaprofenic acid—Drowsiness—Doxorubicin—liver cancer	0.00218	0.00356	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTA4—liver cancer	0.00216	0.00596	CbGpPWpGaD
Tiaprofenic acid—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00216	0.00353	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00214	0.00592	CbGpPWpGaD
Tiaprofenic acid—Haemoglobin—Epirubicin—liver cancer	0.00212	0.00348	CcSEcCtD
Tiaprofenic acid—Stomatitis—Doxorubicin—liver cancer	0.00212	0.00347	CcSEcCtD
Tiaprofenic acid—Conjunctivitis—Doxorubicin—liver cancer	0.00212	0.00346	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Epirubicin—liver cancer	0.00211	0.00346	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTA2—liver cancer	0.00211	0.00581	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—liver cancer	0.00209	0.00578	CbGpPWpGaD
Tiaprofenic acid—Sweating—Doxorubicin—liver cancer	0.00209	0.00342	CcSEcCtD
Tiaprofenic acid—Haematuria—Doxorubicin—liver cancer	0.00208	0.0034	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—GGT1—liver cancer	0.00205	0.00567	CbGpPWpGaD
Tiaprofenic acid—Epistaxis—Doxorubicin—liver cancer	0.00205	0.00336	CcSEcCtD
Tiaprofenic acid—PTGS2—S1P1 pathway—VEGFA—liver cancer	0.00204	0.00563	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTA1—liver cancer	0.00203	0.00561	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—NAT2—liver cancer	0.00201	0.00555	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00201	0.00554	CbGpPWpGaD
Tiaprofenic acid—Erythema multiforme—Epirubicin—liver cancer	0.002	0.00327	CcSEcCtD
Tiaprofenic acid—Tinnitus—Epirubicin—liver cancer	0.00197	0.00322	CcSEcCtD
Tiaprofenic acid—Haemoglobin—Doxorubicin—liver cancer	0.00196	0.00322	CcSEcCtD
Tiaprofenic acid—Haemorrhage—Doxorubicin—liver cancer	0.00195	0.0032	CcSEcCtD
Tiaprofenic acid—Fenoprofen—ALB—liver cancer	0.00194	0.0718	CrCbGaD
Tiaprofenic acid—Erythema multiforme—Doxorubicin—liver cancer	0.00185	0.00303	CcSEcCtD
Tiaprofenic acid—Erythema—Epirubicin—liver cancer	0.00184	0.00301	CcSEcCtD
Tiaprofenic acid—Tinnitus—Doxorubicin—liver cancer	0.00182	0.00298	CcSEcCtD
Tiaprofenic acid—Flatulence—Epirubicin—liver cancer	0.00181	0.00297	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.00178	0.00491	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Overview of nanoparticle effects—IL6—liver cancer	0.00177	0.0049	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00177	0.00489	CbGpPWpGaD
Tiaprofenic acid—Muscle spasms—Epirubicin—liver cancer	0.00177	0.00289	CcSEcCtD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—TNF—liver cancer	0.00175	0.00482	CbGpPWpGaD
Tiaprofenic acid—Vision blurred—Epirubicin—liver cancer	0.00173	0.00284	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—liver cancer	0.00171	0.00472	CbGpPWpGaD
Tiaprofenic acid—Erythema—Doxorubicin—liver cancer	0.0017	0.00279	CcSEcCtD
Tiaprofenic acid—Anaemia—Epirubicin—liver cancer	0.0017	0.00278	CcSEcCtD
Tiaprofenic acid—Flatulence—Doxorubicin—liver cancer	0.00168	0.00274	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—liver cancer	0.00166	0.00459	CbGpPWpGaD
Tiaprofenic acid—Vertigo—Epirubicin—liver cancer	0.00165	0.0027	CcSEcCtD
Tiaprofenic acid—Muscle spasms—Doxorubicin—liver cancer	0.00164	0.00268	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—GGT1—liver cancer	0.00163	0.0045	CbGpPWpGaD
Tiaprofenic acid—Palpitations—Epirubicin—liver cancer	0.00162	0.00266	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—HPGDS—liver cancer	0.00161	0.00443	CbGpPWpGaD
Tiaprofenic acid—Vision blurred—Doxorubicin—liver cancer	0.0016	0.00263	CcSEcCtD
Tiaprofenic acid—Anaemia—Doxorubicin—liver cancer	0.00157	0.00257	CcSEcCtD
Tiaprofenic acid—Chest pain—Epirubicin—liver cancer	0.00157	0.00256	CcSEcCtD
Tiaprofenic acid—Anxiety—Epirubicin—liver cancer	0.00156	0.00255	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00154	0.00424	CbGpPWpGaD
Tiaprofenic acid—Dry mouth—Epirubicin—liver cancer	0.00153	0.00251	CcSEcCtD
Tiaprofenic acid—Vertigo—Doxorubicin—liver cancer	0.00153	0.0025	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—liver cancer	0.00152	0.00419	CbGpPWpGaD
Tiaprofenic acid—Palpitations—Doxorubicin—liver cancer	0.0015	0.00246	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Epirubicin—liver cancer	0.0015	0.00246	CcSEcCtD
Tiaprofenic acid—Oedema—Epirubicin—liver cancer	0.0015	0.00246	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—MTHFR—liver cancer	0.0015	0.00414	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00148	0.0041	CbGpPWpGaD
Tiaprofenic acid—Thrombocytopenia—Epirubicin—liver cancer	0.00147	0.00241	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Epirubicin—liver cancer	0.00145	0.00238	CcSEcCtD
Tiaprofenic acid—Chest pain—Doxorubicin—liver cancer	0.00145	0.00237	CcSEcCtD
Tiaprofenic acid—Anxiety—Doxorubicin—liver cancer	0.00144	0.00236	CcSEcCtD
Tiaprofenic acid—Anorexia—Epirubicin—liver cancer	0.00143	0.00234	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—liver cancer	0.00143	0.00395	CbGpPWpGaD
Tiaprofenic acid—Dry mouth—Doxorubicin—liver cancer	0.00142	0.00232	CcSEcCtD
Tiaprofenic acid—PTGS2—Overview of nanoparticle effects—IL6—liver cancer	0.00141	0.00389	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—GSTM1—liver cancer	0.0014	0.00386	CbGpPWpGaD
Tiaprofenic acid—Oedema—Doxorubicin—liver cancer	0.00139	0.00227	CcSEcCtD
Tiaprofenic acid—Anaphylactic shock—Doxorubicin—liver cancer	0.00139	0.00227	CcSEcCtD
Tiaprofenic acid—Thrombocytopenia—Doxorubicin—liver cancer	0.00136	0.00223	CcSEcCtD
Tiaprofenic acid—Insomnia—Epirubicin—liver cancer	0.00136	0.00222	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Epirubicin—liver cancer	0.00135	0.00221	CcSEcCtD
Tiaprofenic acid—Hyperhidrosis—Doxorubicin—liver cancer	0.00134	0.0022	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Epirubicin—liver cancer	0.00134	0.00219	CcSEcCtD
Tiaprofenic acid—Somnolence—Epirubicin—liver cancer	0.00133	0.00218	CcSEcCtD
Tiaprofenic acid—Anorexia—Doxorubicin—liver cancer	0.00132	0.00217	CcSEcCtD
Tiaprofenic acid—Dyspepsia—Epirubicin—liver cancer	0.00132	0.00216	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.00132	0.00364	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—F2—liver cancer	0.00132	0.00363	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—CYP2E1—liver cancer	0.00131	0.00361	CbGpPWpGaD
Tiaprofenic acid—Decreased appetite—Epirubicin—liver cancer	0.0013	0.00214	CcSEcCtD
Tiaprofenic acid—Fatigue—Epirubicin—liver cancer	0.00129	0.00212	CcSEcCtD
Tiaprofenic acid—Constipation—Epirubicin—liver cancer	0.00128	0.0021	CcSEcCtD
Tiaprofenic acid—Flurbiprofen—ALB—liver cancer	0.00127	0.0468	CrCbGaD
Tiaprofenic acid—Insomnia—Doxorubicin—liver cancer	0.00126	0.00206	CcSEcCtD
Tiaprofenic acid—Paraesthesia—Doxorubicin—liver cancer	0.00125	0.00204	CcSEcCtD
Tiaprofenic acid—Dyspnoea—Doxorubicin—liver cancer	0.00124	0.00203	CcSEcCtD
Tiaprofenic acid—Somnolence—Doxorubicin—liver cancer	0.00123	0.00202	CcSEcCtD
Tiaprofenic acid—Gastrointestinal pain—Epirubicin—liver cancer	0.00123	0.00201	CcSEcCtD
Tiaprofenic acid—Dyspepsia—Doxorubicin—liver cancer	0.00122	0.002	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.00121	0.00333	CbGpPWpGaD
Tiaprofenic acid—Decreased appetite—Doxorubicin—liver cancer	0.00121	0.00198	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GGT1—liver cancer	0.0012	0.00332	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	0.0012	0.00331	CbGpPWpGaD
Tiaprofenic acid—Fatigue—Doxorubicin—liver cancer	0.0012	0.00196	CcSEcCtD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.0012	0.0033	CbGpPWpGaD
Tiaprofenic acid—Urticaria—Epirubicin—liver cancer	0.00119	0.00195	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—MTHFR—liver cancer	0.00119	0.00328	CbGpPWpGaD
Tiaprofenic acid—Constipation—Doxorubicin—liver cancer	0.00119	0.00194	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Epirubicin—liver cancer	0.00119	0.00194	CcSEcCtD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00118	0.00325	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00117	0.00324	CbGpPWpGaD
Tiaprofenic acid—Ketoprofen—ALB—liver cancer	0.00115	0.0424	CrCbGaD
Tiaprofenic acid—Gastrointestinal pain—Doxorubicin—liver cancer	0.00114	0.00186	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.00111	0.00308	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—liver cancer	0.00111	0.00306	CbGpPWpGaD
Tiaprofenic acid—Hypersensitivity—Epirubicin—liver cancer	0.00111	0.00181	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—liver cancer	0.00111	0.00305	CbGpPWpGaD
Tiaprofenic acid—Urticaria—Doxorubicin—liver cancer	0.0011	0.00181	CcSEcCtD
Tiaprofenic acid—Abdominal pain—Doxorubicin—liver cancer	0.0011	0.0018	CcSEcCtD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—SERPINE1—liver cancer	0.00109	0.00302	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—ALB—liver cancer	0.00109	0.00302	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTP1—liver cancer	0.00108	0.00298	CbGpPWpGaD
Tiaprofenic acid—Asthenia—Epirubicin—liver cancer	0.00108	0.00176	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—liver cancer	0.00108	0.00297	CbGpPWpGaD
Tiaprofenic acid—Pruritus—Epirubicin—liver cancer	0.00106	0.00174	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—F2—liver cancer	0.00104	0.00288	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—APCS—liver cancer	0.00103	0.00286	CbGpPWpGaD
Tiaprofenic acid—Diarrhoea—Epirubicin—liver cancer	0.00103	0.00168	CcSEcCtD
Tiaprofenic acid—Hypersensitivity—Doxorubicin—liver cancer	0.00102	0.00167	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.001	0.00277	CbGpPWpGaD
Tiaprofenic acid—Asthenia—Doxorubicin—liver cancer	0.000996	0.00163	CcSEcCtD
Tiaprofenic acid—Dizziness—Epirubicin—liver cancer	0.000992	0.00162	CcSEcCtD
Tiaprofenic acid—PTGS1—Biological oxidations—GSTM1—liver cancer	0.000992	0.00274	CbGpPWpGaD
Tiaprofenic acid—Pruritus—Doxorubicin—liver cancer	0.000982	0.00161	CcSEcCtD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000957	0.00264	CbGpPWpGaD
Tiaprofenic acid—Vomiting—Epirubicin—liver cancer	0.000954	0.00156	CcSEcCtD
Tiaprofenic acid—Diarrhoea—Doxorubicin—liver cancer	0.00095	0.00156	CcSEcCtD
Tiaprofenic acid—Rash—Epirubicin—liver cancer	0.000946	0.00155	CcSEcCtD
Tiaprofenic acid—Dermatitis—Epirubicin—liver cancer	0.000945	0.00155	CcSEcCtD
Tiaprofenic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—liver cancer	0.000944	0.00261	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Biological oxidations—CYP1A1—liver cancer	0.00094	0.0026	CbGpPWpGaD
Tiaprofenic acid—Headache—Epirubicin—liver cancer	0.00094	0.00154	CcSEcCtD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000924	0.00255	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000922	0.00255	CbGpPWpGaD
Tiaprofenic acid—Dizziness—Doxorubicin—liver cancer	0.000918	0.0015	CcSEcCtD
Tiaprofenic acid—Nausea—Epirubicin—liver cancer	0.000891	0.00146	CcSEcCtD
Tiaprofenic acid—Vomiting—Doxorubicin—liver cancer	0.000883	0.00145	CcSEcCtD
Tiaprofenic acid—Rash—Doxorubicin—liver cancer	0.000876	0.00143	CcSEcCtD
Tiaprofenic acid—Dermatitis—Doxorubicin—liver cancer	0.000875	0.00143	CcSEcCtD
Tiaprofenic acid—Headache—Doxorubicin—liver cancer	0.00087	0.00142	CcSEcCtD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000869	0.0024	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—ALB—liver cancer	0.000867	0.00239	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000861	0.00238	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000854	0.00236	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CDKN2A—liver cancer	0.000842	0.00233	CbGpPWpGaD
Tiaprofenic acid—Nausea—Doxorubicin—liver cancer	0.000825	0.00135	CcSEcCtD
Tiaprofenic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—liver cancer	0.000805	0.00222	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00077	0.00213	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000759	0.0021	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CDKN1B—liver cancer	0.000746	0.00206	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000732	0.00202	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000726	0.002	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.000712	0.00196	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000705	0.00195	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—UGDH—liver cancer	0.000703	0.00194	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.000688	0.0019	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—EPT1—liver cancer	0.000661	0.00183	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000661	0.00182	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—TNF—liver cancer	0.000645	0.00178	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—TAT—liver cancer	0.000627	0.00173	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000616	0.0017	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00058	0.0016	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000571	0.00158	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000569	0.00157	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000568	0.00157	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00056	0.00155	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—UGDH—liver cancer	0.000558	0.00154	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000557	0.00154	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000556	0.00154	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000542	0.0015	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000538	0.00148	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000527	0.00146	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000526	0.00145	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—EPT1—liver cancer	0.000525	0.00145	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000521	0.00144	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000512	0.00141	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—TAT—liver cancer	0.000498	0.00137	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000489	0.00135	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000461	0.00127	CbGpPWpGaD
Tiaprofenic acid—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000448	0.00124	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000435	0.0012	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000434	0.0012	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GLUL—liver cancer	0.000426	0.00118	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CPT1B—liver cancer	0.000426	0.00118	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000422	0.00117	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000413	0.00114	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—NR1H4—liver cancer	0.000411	0.00113	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000405	0.00112	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTA3—liver cancer	0.000404	0.00112	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—LTF—liver cancer	0.000404	0.00112	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000387	0.00107	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000379	0.00105	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTA4—liver cancer	0.000369	0.00102	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000369	0.00102	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000368	0.00102	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000366	0.00101	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000365	0.00101	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000361	0.000997	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTA2—liver cancer	0.00036	0.000994	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000357	0.000986	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000357	0.000985	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000348	0.000962	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTA1—liver cancer	0.000347	0.000959	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—NAT2—liver cancer	0.000343	0.000948	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CPT1B—liver cancer	0.000338	0.000934	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GLUL—liver cancer	0.000338	0.000934	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00033	0.000912	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—ALDOB—liver cancer	0.000329	0.000909	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000327	0.000903	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NR1H4—liver cancer	0.000326	0.000901	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000322	0.000888	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTA3—liver cancer	0.000321	0.000885	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CRABP1—liver cancer	0.000314	0.000867	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—ALDOB—liver cancer	0.000312	0.000862	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000296	0.000817	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000295	0.000815	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTA4—liver cancer	0.000293	0.00081	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000287	0.000791	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTA2—liver cancer	0.000286	0.000789	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000283	0.000781	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTA1—liver cancer	0.000276	0.000761	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000276	0.000761	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—HPGDS—liver cancer	0.000275	0.000758	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000273	0.000755	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000273	0.000754	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—NAT2—liver cancer	0.000273	0.000753	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000262	0.000724	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—ALDOB—liver cancer	0.000261	0.000722	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000251	0.000693	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CRABP1—liver cancer	0.000249	0.000689	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000249	0.000686	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—ADAM17—liver cancer	0.000247	0.000681	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000245	0.000678	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PSMA4—liver cancer	0.000245	0.000676	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PSMD10—liver cancer	0.000245	0.000676	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000243	0.000671	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GOT2—liver cancer	0.000238	0.000657	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PSMA4—liver cancer	0.000232	0.00064	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PSMD10—liver cancer	0.000232	0.00064	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—GOT2—liver cancer	0.000226	0.000623	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000225	0.00062	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CYP2E1—liver cancer	0.000224	0.000618	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—HPGDS—liver cancer	0.000218	0.000602	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000217	0.000598	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000217	0.000598	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CYCS—liver cancer	0.000209	0.000578	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GGT1—liver cancer	0.000205	0.000567	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GOT1—liver cancer	0.000205	0.000567	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000205	0.000566	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000197	0.000545	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000195	0.000538	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—GOT1—liver cancer	0.000195	0.000538	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PSMA4—liver cancer	0.000194	0.000536	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PSMD10—liver cancer	0.000194	0.000536	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GOT2—liver cancer	0.000189	0.000522	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTP1—liver cancer	0.000185	0.00051	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—HMOX1—liver cancer	0.000182	0.000503	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PRKCE—liver cancer	0.00018	0.000496	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CYP2E1—liver cancer	0.000178	0.000491	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000172	0.000475	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—GSTM1—liver cancer	0.00017	0.000468	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CYCS—liver cancer	0.000166	0.000459	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GGT1—liver cancer	0.000163	0.00045	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GOT1—liver cancer	0.000163	0.00045	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—CYP1A1—liver cancer	0.000161	0.000444	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—H2AFX—liver cancer	0.000157	0.000433	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—MTHFR—liver cancer	0.00015	0.000414	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PPARA—liver cancer	0.000147	0.000406	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTP1—liver cancer	0.000147	0.000405	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—HMOX1—liver cancer	0.000145	0.000399	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—MTHFR—liver cancer	0.000142	0.000392	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—TERT—liver cancer	0.000142	0.000391	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—GSTM1—liver cancer	0.000135	0.000372	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000132	0.000365	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—CYP1A1—liver cancer	0.000128	0.000352	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PIK3CG—liver cancer	0.000126	0.000348	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PPARG—liver cancer	0.000122	0.000336	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—APC—liver cancer	0.000119	0.00033	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—MTHFR—liver cancer	0.000119	0.000329	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PPARA—liver cancer	0.000117	0.000322	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—BRAF—liver cancer	0.000112	0.00031	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PIK3CD—liver cancer	0.000111	0.000306	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—ALB—liver cancer	0.000109	0.000302	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PIK3CD—liver cancer	0.000105	0.00029	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000105	0.00029	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—SERPINE1—liver cancer	0.000104	0.000287	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PIK3CG—liver cancer	0.0001	0.000276	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PIK3CB—liver cancer	9.65e-05	0.000266	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PPARG—liver cancer	9.65e-05	0.000266	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—RAF1—liver cancer	9.37e-05	0.000259	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—MTOR—liver cancer	9.15e-05	0.000253	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PIK3CB—liver cancer	9.15e-05	0.000253	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PIK3CD—liver cancer	8.79e-05	0.000243	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—ALB—liver cancer	8.68e-05	0.00024	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—CDKN1B—liver cancer	8.58e-05	0.000237	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—CTNNB1—liver cancer	8.11e-05	0.000224	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—CDKN1A—liver cancer	7.92e-05	0.000219	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PIK3CB—liver cancer	7.66e-05	0.000212	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—STAT3—liver cancer	7.07e-05	0.000195	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—MYC—liver cancer	6.57e-05	0.000181	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—TGFB1—liver cancer	6.55e-05	0.000181	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—KRAS—liver cancer	6.07e-05	0.000168	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—PIK3CA—liver cancer	5.88e-05	0.000162	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—PIK3CA—liver cancer	5.58e-05	0.000154	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—HRAS—liver cancer	5.16e-05	0.000142	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—IL6—liver cancer	4.94e-05	0.000136	CbGpPWpGaD
Tiaprofenic acid—PTGS1—Metabolism—AKT1—liver cancer	4.81e-05	0.000133	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—PIK3CA—liver cancer	4.67e-05	0.000129	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Disease—AKT1—liver cancer	4.56e-05	0.000126	CbGpPWpGaD
Tiaprofenic acid—PTGS2—Metabolism—AKT1—liver cancer	3.82e-05	0.000105	CbGpPWpGaD
